Blueblood VenturesBOM:539637 EBITDA Margin % is 58.58% as of Mar. 2026, which is 694% above its 10-year median of 7.38. The stock has 6 warning signs investors should review.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Blueblood Ventures's EBITDA for the
six
months ended in Mar. 2026 was ₹-1.27 Mil. Blueblood Ventures's Revenue for the
six
months ended in Mar. 2026 was ₹-2.16 Mil. Therefore, Blueblood Ventures's EBITDA margin for the quarter that ended in Mar. 2026 was 58.58%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Blueblood Ventures EBITDA Margin % Related Terms
Blueblood Ventures EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Blueblood Ventures's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539637 vs MS, SCHW, GS: EBITDA Margin % Comparison
For the Capital Markets subindustry, Blueblood Ventures's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blueblood Ventures EBITDA Margin % vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, Blueblood Ventures's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Blueblood Ventures's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blueblood Ventures (BOM:539637) has a EBITDA Margin % of 58.58% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Blueblood Ventures and its competitors. This is 694% above median its historical median of 7.38.
Is Blueblood Ventures' EBITDA Margin % too high?
Blueblood Ventures' current EBITDA Margin % of 58.58% is 694% above median its 10-year median of 7.38. The Capital Markets industry median EBITDA Margin % is 20.73. Blueblood Ventures' value of 58.58% is 182.6% above this industry median.
How does Blueblood Ventures' EBITDA Margin % compare to MS and SCHW?
Blueblood Ventures' EBITDA Margin % of 58.58% can be compared against companies in the Capital Markets industry. The industry median EBITDA Margin % is 20.73. Blueblood Ventures' value of 58.58% is 182.6% above this benchmark. While the company's 10-year median is 7.38 vs. the industry median of 20.73, Blueblood Ventures has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Capital Markets company?
The median EBITDA Margin % among Capital Markets companies is 20.73, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blueblood Ventures's current EBITDA Margin % of 58.58% is 182.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Blueblood Ventures and its competitors. For the Capital Markets industry, the median EBITDA Margin % is 20.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blueblood Ventures's current EBITDA Margin % is 58.58%, which is 694% above median its own 10-year median of 7.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blueblood Ventures stock overvalued right now?
Blueblood Ventures (BOM:539637) has a current EBITDA Margin % of 58.58%. The stock's GF Value™ is ₹1.65, compared to a current price of ₹11.07 — trading 570.9% above its estimated fair value. The current EBITDA Margin % is 58.58%, which is 694% above median its 10-year median of 7.38 and 182.6% above the Capital Markets industry median of 20.73. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Blueblood Ventures (BOM:539637), the current EBITDA Margin % is 58.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Blueblood Ventures Ltd is engaged in the business of equity investment and trading in equity, derivatives, commodities, futures, and options, as well as other financial products. It also provides management and business consultancy. The company receives revenue from the sale of shares, securities, and commodities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539637 has been successfully added to your 